Evidence map›Paper›PMID 29678753›Full record

ArticleNeuroscience2018

Human Apolipoprotein E Genotype Differentially Affects Olfactory Behavior and Sensory Physiology in Mice.

Brett S East, Gloria Fleming, Kathy Peng, Jonas K Olofsson, Efrat Levy, Paul M Mathews, Donald A Wilson

Abstract read
In one paragraph

Article in Neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Sex andToxics · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Older, non-demented apolipoprotein εNeurobiology of aging · 2020
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Brett S EastEmotional Brain Institute, Nathan S. Kline Institute, Orangeburg, NY 10962, USA; Department of Child & Adolescent Psychiatry, New York University School of Medicine, New York, NY 10016, USA. Electronic address: brett.east@nki.rfmh.org.
Gloria FlemingEmotional Brain Institute, Nathan S. Kline Institute, Orangeburg, NY 10962, USA.
Kathy PengCenter for Dementia Research, Nathan S. Kline Institute, Orangeburg, NY 10962, USA; Department of Neurology, New York University School of Medicine, New York, NY 10016, USA.
Jonas K OlofssonEmotional Brain Institute, Nathan S. Kline Institute, Orangeburg, NY 10962, USA; Department of Child & Adolescent Psychiatry, New York University School of Medicine, New York, NY 10016, USA; Department of Psychology, Stockholm University, SE-10691 Stockholm, Sweden.
Efrat LevyCenter for Dementia Research, Nathan S. Kline Institute, Orangeburg, NY 10962, USA; Department of Biochemistry & Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA; Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA; The Neuroscience Institute, New York University School of Medicine, New York, NY 10016, USA.
Paul M MathewsCenter for Dementia Research, Nathan S. Kline Institute, Orangeburg, NY 10962, USA; Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA.
Donald A WilsonEmotional Brain Institute, Nathan S. Kline Institute, Orangeburg, NY 10962, USA; Department of Child & Adolescent Psychiatry, New York University School of Medicine, New York, NY 10016, USA; The Neuroscience Institute, New York University School of Medicine, New York, NY 10016, USA; Department of Neuroscience & Physiology, New York University School of Medicine, New York, NY 10016, USA.
Nathan Kline Institute for Psychiatric Research · US

Funding

Uncovering Alzheimer's disease risk mechanisms through neuron-specific analysis of autophagy and endosomal-lysosomal functionP01AG017617 · NIA · NATHAN S. KLINE INSTITUTE FOR PSYCH RES · PI NIXON, RALPH A. · 2000 to 2021
$40.0M
Postdoctoral Research Training in Neurodegenerative Disorders and the Aging BrainT32AG052909 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Helen E Scharfman, THOMAS M WISNIEWSKI · 2017 to 2026
$2.5M
Neuronal Protective Apolipoprotein E2-mediated endocytic and exocytic pathwaysRF1AG057517 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LEVY, EFRAT, MATHEWS, PAUL M · 2017 to 2020
$2.4M
NIA NIH HHS P01 AG017617NIA NIH HHS RF1 AG057517NIA NIH HHS T32 AG052909
6 · The paper itself

Abstract

Apolipoprotein E (ApoE) is an important lipid carrier in both the periphery and the brain. The ApoE ε4 allele (ApoE4) is the single most important genetic risk-factor for Alzheimer's disease (AD) while the ε2 allele (ApoE2) is associated with a lower risk of AD-related neurodegeneration compared to the most common variant, ε3 (ApoE3). ApoE genotype affects a variety of neural circuits; however, the olfactory system appears to provide early biomarkers of ApoE genotype effects. Here, we directly compared olfactory behavior and olfactory system physiology across all three ApoE genotypes in 6-month- and 12-month-old mice with targeted replacement for the human ApoE2, ApoE3, or ApoE4 genes. Odor investigation and habituation were assessed, along with, olfactory bulb and piriform cortical local field potential activity. The results demonstrate that while initial odor investigation was unaffected by ApoE genotype, odor habituation was impaired in E4 relative to E2 mice, with E3 mice intermediate in function. There was also significant deterioration of odor habituation from 6 to 12 months of age regardless of the ApoE genotype. Olfactory system excitability and odor responsiveness were similarly determined by ApoE genotype, with an ApoE4 > ApoE3 > ApoE2 excitability ranking. Although motivated behavior is influenced by many processes, hyper-excitability of ApoE4 mice may contribute to impaired odor habituation, while hypo-excitability of ApoE2 mice may contribute to its protective effects. Given that these ApoE mice do not have AD pathology, our results demonstrate how ApoE affects the olfactory system at early stages, prior to the development of AD.

Indexed as

AnimalsApolipoprotein E2Apolipoprotein E3Apolipoprotein E4Behavior, AnimalGenotypeHabituation, PsychophysiologicHumansMiceMice, Inbred C57BLMice, TransgenicSmellApolipoprotein E2Apolipoprotein E3Apolipoprotein E4Alzheimer’s diseaseapolipoprotein Eodor habituationolfactionolfactory bulbpiriform cortex

Identifiers

PMID29678753
PMCPMC5959295
OpenAlexW2799413617

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.